Anticoagulation With Enhanced Gastrointestinal Safety

Anticoagulation With Enhanced Gastrointestinal Safety
Conditions: Upper Gastrointestinal Bleeding; Peptic Ulcer Hemorrhage; Anticoagulant-induced Bleeding

Interventions: Behavioral: Clinician Notification with Nurse Facilitation (CNNF); Behavioral: Wait list control

Sponsors: University of Michigan; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

May 1, 2024Comments OffClinicalTrials.gov | Gastroenterology Clinical Trials | Gastroenterology Studies | US National Library of Medicine
Comments